• BCV Floatptosis in Macrophages: Mechanism and Methods

  2026-08-30

  The Cell Discovery study identifies a Bergeyella cardium variant that causes a distinct lysosome-fusion-associated cytoplasmic vacuolization death in macrophages, termed floatptosis. Its combination of bacterial, vesicle, protein, pharmacological, and genetic experiments links this phenotype to membrane proteins, amiloride-sensitive signaling, and SLC9A9-dependent vacuole fusion, providing a framework for studying infection-associated cell death.

• Astrocyte Heterogeneity Across Space and Time

  2026-08-29

  Schroeder et al. develop a cross-species, developmental single-nucleus transcriptomic atlas showing that astrocyte regional identity is established early but remodeled after birth. The study combines molecular profiling with expansion microscopy to connect gene-expression divergence to regional morphology, providing a framework for interpreting astrocyte specialization and for designing spatial validation experiments.

• PPACK Dihydrochloride for Thrombin Assays

  2026-08-28

  PPACK Dihydrochloride provides a high-affinity, irreversible way to suppress thrombin activity in purified enzyme, plasma, and platelet workflows. Its covalent mechanism helps separate thrombin-dependent effects from receptor-specific platelet signaling, improving interpretation of coagulation and aggregation experiments.

• Ouabain Workflows for Na+/K+-ATPase Research

  2026-08-28

  Build reproducible Ouabain experiments that connect pump inhibition with sodium, calcium, membrane-potential, and vascular-tone readouts. This guide translates a recent mesenteric arteriole study into practical cell, vessel, and translational workflows while keeping evidence-backed product details separate from assay recommendations.

• SZQ-3 Targets NF-κB in Postmenopausal Osteoporosis

  2026-08-27

  The 2026 FASEB Journal study identifies SZQ-3, a synthetic chromone–maleimide hybrid, as a dual-action candidate that protects osteoblasts and suppresses osteoclast differentiation. Its proposed mechanism links NF-κB inhibition with preservation of mitochondrial function in estrogen-deficiency-related bone loss, although validation beyond cellular and mouse models remains necessary.

• Romidepsin (FK228) Workflow for Cancer Research

  2026-08-27

  Romidepsin and FK228 provide a focused way to connect class I HDAC inhibition with chromatin, cell-cycle, and apoptosis readouts. This workflow also adapts thermal proteomics and ubiquitinomic concepts from recent NSCLC research to strengthen mechanism-of-action studies without conflating distinct compounds.

• VE-821: ATR Kinase Inhibitor Workflows

  2026-08-26

  VE-821 provides a practical way to interrogate ATR-dependent checkpoint signaling, radiosensitization, and chemotherapy response while preserving a relatively selective kinase profile. This guide connects established DNA damage assays with an exploratory framework inspired by new findings on DNMT1-controlled human bocavirus 1 replication.

• Paroxetine Mesylate Research Workflows

  2026-08-26

  Paroxetine Mesylate supports integrated serotonin-transporter, CYP2D6, kinase, and colorectal cancer workflows rather than single-endpoint testing. This guide converts its multi-target pharmacology into practical assay design, dosing, controls, and troubleshooting decisions.

• 6-FAM SE Workflows for Durable Biomolecule Labeling

  2026-08-25

  6-FAM SE enables durable, amine-directed fluorescent labeling of proteins, peptides, and amino-modified nucleic acids for sequencing, binding, and uptake studies. This practical guide connects its workflow advantages with the GSH-responsive MOF melanoma platform while clearly separating analytical tracking from therapeutic function.

• Phebestin: Bestatin-Related Antiplasmodial Inhibition

  2026-08-25

  The reference study identifies phebestin, a Bestatin-related aminopeptidase inhibitor, as a nanomolar inhibitor of Plasmodium falciparum growth with activity against both chloroquine-sensitive and chloroquine-resistant parasites. Its combination of phenotypic assays, stage profiling, washout experiments, molecular docking, and mouse models provides a useful framework for evaluating aminopeptidase-directed antimalarial candidates.

• Novobiocin: From Target Biology to Assay Decisions

  2026-08-24

  Novobiocin is an aminocoumarin antibiotic whose effects on bacterial DNA gyrase, Hsp90, parasites, and selected viruses require careful assay interpretation. This guide translates target biology and piroplasm research into practical decisions about selectivity, controls, exposure, and readouts.

• Late-Stage Mechanics of Clathrin-Mediated Endocytosis

  2026-08-24

  Wu and colleagues use multi-dimensional single-particle tracking to map rotational motions associated with the final stages of clathrin-mediated endocytosis in living cells. The study distinguishes a common dynamin-associated in-plane twist from an actin-associated out-of-plane swing, showing that late-stage mechanical behavior is heterogeneous rather than governed by one obligatory motion.

• IWR-1-endo: Mechanism and Research Workflow

  2026-08-23

  IWR-1-endo is a small-molecule Wnt signaling inhibitor that promotes β-catenin destruction through Axin-complex stabilization. Its reported activity in DLD-1 colorectal cancer cells and zebrafish regeneration models supports research use, while product handling and model-specific limits remain important.

• Candida krusei Apoptosis Pathways in BMECs

  2026-08-22

  The reference study shows that the yeast and hypha phases of Candida krusei trigger apoptosis in bovine mammary epithelial cells through partly distinct mechanisms. Its phase-resolved co-culture design links yeast-associated injury primarily to mitochondrial signaling and hypha-associated injury to death ligand/receptor signaling, while identifying TLR2/ERK and JNK/ERK as shared regulatory nodes.

• Wnt-C59: A Compartment-Aware Wnt Causality Guide

  2026-08-22

  Wnt-C59 is a potent PORCN inhibitor for separating Wnt ligand maturation from exosomal transport and downstream β-catenin responses. This guide translates recent BMSC osteogenesis findings into rigorous assay decisions while connecting the same pathway to cancer biology.

8053 records 1/537 page Next 12345 下5页 Last page